Latest News about TAK
Recent news which mentions TAK
Why Novavax Stock Is Rising Today
December 16, 2021
From Motley Fool
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
December 16, 2021
From Benzinga
Novavax Files For Approval Of Its COVID-19 Vaccine In Japan
December 16, 2021
From Benzinga
3 Stocks That Can Make You Rich in Just a Few Years
December 14, 2021
From InvestorPlace
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
December 13, 2021
From Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
From InvestorPlace
2 Ultra-High-Yield Dividend Stocks to Buy as a Hedge Against Inflation
November 30, 2021
From Motley Fool
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
November 28, 2021
From Benzinga
The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension
November 24, 2021
From Benzinga
Takeda's Maribavir Scores FDA Approval For Post-Transplant CMV Infection
November 24, 2021
From Benzinga
The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
November 23, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
November 21, 2021
From Benzinga
Takeda, Shattuck Labs Terminate Immuno-Oncology Pact
November 09, 2021
From Benzinga
Here's Why BioCryst Pharmaceuticals Stock Is Losing Ground Today
November 03, 2021
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
From Benzinga
From Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
From Benzinga
7 Reasons Why Novavax Is a No-Brainer Pick Over Ocugen
October 21, 2021
From Motley Fool
Leading the Charge to Develop the First Orexin-Targeted Therapy to Address Narcolepsy at its Root Cause
October 20, 2021
From Benzinga
From Benzinga
From Benzinga
Calithera Buys Two Oncology Candidates From Takeda For $45M
October 19, 2021
From Benzinga
From Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
October 13, 2021
From Motley Fool
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
From Benzinga
Why Takeda Pharmaceutical Stock Is Down More Than 10% Today
October 06, 2021
Tickers
TAK
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 06, 2021
From Benzinga
BofA Downgrades Takeda On Suspension Narcolepsy Drug Trials
October 06, 2021
Tickers
TAK
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.